185 studies found for:    Open Studies | "Tuberculosis"
Show Display Options
Rank Status Study
1 Recruiting Positron Emission Tomography in Extrapulmonary Tuberculosis
Conditions: Extrapulmonary Tuberculosis;   Lymph Node Tuberculosis;   Bone Tuberculosis
Intervention: Other: Positron Emission Tomography with 18F-Fluoro-deoxy-glucose
2 Unknown  Prospective Comparison of the Tuberculin Skin Test and Interferon-Gamma Release Assays in Diagnosing Infection With Mycobacterium Tuberculosis and in Predicting Progression to Tuberculosis
Conditions: Latent Tuberculosis Infection;   Tuberculosis Disease
Intervention:
3 Recruiting Multi-Drug Resistant Tuberculosis in Korea
Conditions: Tuberculosis;   Pulmonary Tuberculosis
Intervention:
4 Unknown  Surveillance and Follow-up for Latent Tuberculosis Infection and Observation of the Effect of Prophylactic Latent Tuberculosis Treatment in Patients With Severe Chronic Kidney Disease or Receiving Long-term Dialysis
Conditions: To Determine the Prevalence of Latent Tuberculosis in Each Group;   To Monitor the Occurrence of Active Tuberculosis
Intervention:
5 Unknown  Pharmacokinetics of Anti-tuberculosis Drugs in Gastrectomized Patients
Conditions: Tuberculosis;   Tuberculosis, Pulmonary;   Early Gastric Cancer
Intervention:
6 Unknown  Diagnosis of Tuberculosis Infection in HIV Co-infected Children
Conditions: Latent Tuberculosis Infection;   Tuberculosis;   HIV Infections
Intervention:
7 Unknown  Intestinal Tuberculosis Diagnostics and the Differentiation From Crohn's Disease
Conditions: Intestinal Tuberculosis;   Pulmonary Tuberculosis;   Crohn's Disease
Intervention:
8 Unknown  Use TST and QFT-RD1 Test to Monitor the Tuberculous Infection in Patients, Close Contact People and Health Care Workers
Conditions: Tuberculosis;   Latent Tuberculosis;   Tuberculosis Contact;   Elderly
Intervention: Drug: tuberculin for skin test
9 Recruiting A Phase I/IIa Safety & Immunogenicity of AERAS-456 in HIV-Negative Adults With & Without Latent Tuberculosis Infection (C-035-456)
Conditions: Latent Tuberculosis Bacteriology and Histology Unknown;   Latent Tuberculosis
Interventions: Biological: AERAS-456;   Biological: Placebo
10 Unknown  Impact of HIV Infection on Latent Tuberculosis (TB) Among Patients With HIV-TB Co-infection
Conditions: Latent Tuberculosis Infection;   HIV Infections;   Tuberculosis
Intervention:
11 Recruiting Pharmacokinetic and Safety Trial to Determine the Appropriate Dose for Pediatric Patients With Multidrug Resistant Tuberculosis
Conditions: Multidrug Resistant Tuberculosis;   Pediatric
Interventions: Drug: 100 mg Delamanid;   Drug: 50 mg Delamanid
12 Recruiting A 6-Month Safety, Efficacy, and Pharmacokinetic Trial of Delamanid in Pediatric Patients With Multidrug Resistant Tuberculosis
Conditions: Multidrug Resistant Tuberculosis;   Pediatric
Intervention: Drug: Delamanid
13 Recruiting Evaluating the Safety and Effectiveness of Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection
Conditions: Tuberculosis;   HIV Infections
Interventions: Drug: Rifapentine (RPT);   Drug: Isoniazid (INH);   Dietary Supplement: Pyridoxine (Vitamin B6)
14 Recruiting Trial in Pulmonary Tuberculosis Patients With Diabetes Mellitus
Conditions: Diabetes Mellitus;   Pulmonary Tuberculosis
Intervention: Procedure: intensive monitoring
15 Unknown  Treatment Duration for Abdominal Tuberculosis
Condition: Treatment Duration for Abdominal Tuberculosis
Interventions: Drug: RNTCP Category I treatment for 6 months;   Drug: RNTCP Category I treatment for 9months
16 Unknown  Rapid Diagnosis of Pulmonary Tuberculosis
Condition: Tuberculosis
Interventions: Drug: Salbutamol;   Drug: Sodium chloride 5%
17 Unknown  Pharmacokinetics (PK) and Safety of 2 Different Doses of Lopinavir/Ritonavir in in HIV/Tuberculosis (TB) Co-infected Patients Receiving Rifampicin Containing Anti-tuberculosis Therapy
Conditions: HIV Infections;   Tuberculosis
Intervention: Drug: LPV/r
18 Unknown  Study of Latent Tuberculosis Infection (LTBI) by High Resolution Scanner
Condition: Tuberculosis
Intervention:
19 Unknown  A Controlled Trial of a 4-Month Quinolone-Containing Regimen for the Treatment of Pulmonary Tuberculosis
Condition: Tuberculosis
Intervention: Drug: Gatifloxacin combined regimen
20 Not yet recruiting A Phase 2 Open Label Partially Randomized Trial to Evaluate the Efficacy, Safety and Tolerability of Combinations of Bedaquiline, Moxifloxacin, PA-824 and Pyrazinamide in Adult Subjects With Drug-Sensitive or Multi Drug-Resistant Pulmonary Tuberculosis.
Condition: Tuberculosis
Interventions: Drug: Pa-824;   Drug: bedaquiline;   Drug: moxifloxacin;   Drug: pyraziminide;   Drug: isoniazid, rifampicin, pyrazinamide and ethambutol combination tablet

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years